GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,769,000 | +5.1% | 439,745 | -1.5% | 0.10% | +5.4% |
| Q2 2019 | $17,864,000 | -5.8% | 446,377 | -1.6% | 0.09% | -7.0% |
| Q1 2019 | $18,960,000 | +23.0% | 453,691 | +12.5% | 0.10% | +12.4% |
| Q4 2018 | $15,414,000 | -15.3% | 403,388 | -11.0% | 0.09% | -5.3% |
| Q3 2018 | $18,207,000 | -3.8% | 453,242 | -3.4% | 0.09% | -9.6% |
| Q2 2018 | $18,920,000 | +2.5% | 469,352 | -0.7% | 0.10% | +1.0% |
| Q1 2018 | $18,465,000 | +43.6% | 472,612 | +30.4% | 0.10% | +37.3% |
| Q4 2017 | $12,858,000 | -39.8% | 362,524 | -31.0% | 0.08% | -40.9% |
| Q3 2017 | $21,344,000 | +14.2% | 525,705 | +21.3% | 0.13% | +11.4% |
| Q2 2017 | $18,685,000 | +21.0% | 433,330 | +18.3% | 0.11% | +16.3% |
| Q1 2017 | $15,445,000 | +39.1% | 366,337 | +27.0% | 0.10% | +46.3% |
| Q4 2016 | $11,107,000 | -48.6% | 288,473 | -42.4% | 0.07% | -50.4% |
| Q3 2016 | $21,589,000 | -10.4% | 500,607 | -10.0% | 0.14% | -8.8% |
| Q2 2016 | $24,099,000 | +16.0% | 556,087 | +8.5% | 0.15% | +14.7% |
| Q1 2016 | $20,783,000 | +21.6% | 512,580 | +21.0% | 0.13% | +22.9% |
| Q4 2015 | $17,095,000 | -10.8% | 423,711 | -15.0% | 0.10% | -18.6% |
| Q3 2015 | $19,163,000 | -12.2% | 498,441 | -4.8% | 0.13% | -7.9% |
| Q2 2015 | $21,815,000 | +8.8% | 523,818 | +20.6% | 0.14% | +8.5% |
| Q1 2015 | $20,049,000 | +44.9% | 434,489 | +34.2% | 0.13% | +37.2% |
| Q4 2014 | $13,839,000 | -15.3% | 323,839 | -8.9% | 0.09% | -18.3% |
| Q3 2014 | $16,335,000 | -18.4% | 355,385 | -5.0% | 0.12% | -17.3% |
| Q2 2014 | $20,014,000 | -1.1% | 374,273 | -1.2% | 0.14% | +87.8% |
| Q1 2014 | $20,235,000 | +2.1% | 378,753 | +2.0% | 0.07% | -3.9% |
| Q4 2013 | $19,824,000 | +17.7% | 371,344 | +10.6% | 0.08% | +16.7% |
| Q3 2013 | $16,842,000 | +12.9% | 335,727 | +12.5% | 0.07% | 0.0% |
| Q2 2013 | $14,916,000 | – | 298,537 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |